Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | PKM | P14618 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL977788 | 0.93 | TP53 (0.34) | TP53MAPTHPGDTSHRALDH1A1 | |
| SCHEMBL977073 | 0.93 | GRM2 (0.31) | GRM2 | |
| SCHEMBL6864533 | 0.91 | MGLL (0.34) | — | |
| SCHEMBL12922163 | 0.91 | GRM2 (0.35) | LMNAMEN1KMT2AGRM2HTT | |
| SCHEMBL976037 | 0.91 | TP53 (0.34) | TP53MAPTHPGDTSHRALDH1A1 | |
| SCHEMBL977288 | 0.90 | TP53 (0.33) | TP53MAPTHPGDTSHRALDH1A1 | |
| SCHEMBL976788 | 0.90 | TP53 (0.33) | TP53MAPTHPGDTSHRALDH1A1 | |
| SCHEMBL975728 | 0.89 | NLRP3 (0.33) | — | |
| SCHEMBL977986 | 0.88 | TP53 (0.33) | TP53MAPTHPGDTSHRALDH1A1 | |
| SCHEMBL13715838 | 0.88 | MEN1 (0.30) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070173570-A1 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | FUSO FRANCESCO | 2007-07-26 | — | — | US | claimed |
| EP-1341763-B1 | N-ALKOXY-4,4-DIOXY-POLYALKYL-PIPERIDINE COMPOUNDS, WITH GLYCIDYL OR ALKYLCARBONYL GROUPS AS FUNCTIONAL INITIATORS FOR CONTROLLED RADICAL POLYMERIZATION | CIBA SC HOLDING AG (CH) | 2004-06-16 | — | — | EP | claimed |
| US-20040049043-A1 | N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | CIBA SPECIALTY CHEMICALS CORP. | 2004-03-11 | — | — | US | claimed |
| US-7868171-B2 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as radical polymerization initiators | CIBA SPECIALTY CHEMICALS CORP. (US) | 2011-01-11 | — | — | US | disclosed |
| US-7868171-B2 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as radical polymerization initiators | CIBA SPECIALTY CHEMICALS CORP. (US) | 2011-01-11 | — | — | US | disclosed |
| US-7868171-B2 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as radical polymerization initiators | CIBA SPECIALTY CHEMICALS CORP. (US) | 2011-01-11 | — | — | US | disclosed |
| US-20070173570-A1 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | FUSO FRANCESCO | 2007-07-26 | — | — | US | disclosed |
| US-20070173570-A1 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | FUSO FRANCESCO | 2007-07-26 | — | — | US | disclosed |
| US-7235663-B2 | N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization inhibitors | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-06-26 | — | — | US | disclosed |
| US-7235663-B2 | N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization inhibitors | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-06-26 | — | — | US | disclosed |
| US-7235663-B2 | N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization inhibitors | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-06-26 | — | — | US | disclosed |
| EP-1341763-B1 | N-ALKOXY-4,4-DIOXY-POLYALKYL-PIPERIDINE COMPOUNDS, WITH GLYCIDYL OR ALKYLCARBONYL GROUPS AS FUNCTIONAL INITIATORS FOR CONTROLLED RADICAL POLYMERIZATION | CIBA SC HOLDING AG (CH) | 2004-06-16 | — | — | EP | disclosed |
| EP-1341763-A2 | N-ALKOXY-4,4-DIOXY-POLYALKYL-PIPERIDINE COMPOUNDS, WITH GLYCIDYL OR ALKYLCARBONYL GROUPS AS FUNCTIONAL INITIATORS FOR CONTROLLED RADICAL POLYMERIZATION | Ciba SC Holding AG (CH) | 2003-09-10 | — | — | EP | disclosed |
| WO-2002048109-A2 | N-ALKOXY-4,4-DIOXY-POLYALKYL-PIPERIDINES AS RADICAL POLYMERIZATION INITIATORS | CIBA SPECIALTY CHEMICLAS HOLDING INC. (CH) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173570-A1 | N-alkoxy-4, 4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | PTGER4, ALKBH3, PIGO | TP53 4722/4885MAPT 3644/4885HPGD 328/4885 |
| US-20040049043-A1 | N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization | PAOX, ALKBH3, PTGER4 | TP53 4311/4885MAPT 3356/4885HPGD 518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.